Celldex Therapeutics (CLDX) Short-term Investments (2010 - 2026)
Celldex Therapeutics (CLDX) reported Short-term Investments of $670.13 million for Q2 2026, up 10.3% from $607.29 million a year earlier and up 61.2% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Short-term Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Celldex Therapeutics posted Short-term Investments of $489.7 million, down 29.7% from FY2024.
- Short-term Investments has a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
- By year, Short-term Investments came in at $696.93 million in FY2024 (+79.3%), $388.78 million in FY2023 (+41.1%), $275.52 million in FY2022 (-25.4%) and $369.11 million in FY2021 (+145.1%).
- The Q2 2026 figure ranks as the highest quarterly Short-term Investments since Q4 2024.
- Year over year, Short-term Investments gained in three of the last eight quarters, with growth averaging 26.0%.
- The high point for year-over-year Short-term Investments in five years was Q2 2024 (growth of 238.4%); the low point was Q1 2023 (a decline of 36.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $415.73 million (Q1 2026), $489.7 million (Q4 2025) and $547.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Celldex Therapeutics | 2.24 Bn | -28.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 670.13 Mn |
| Mar 31, 2026 | 415.73 Mn |
| Dec 31, 2025 | 489.70 Mn |
| Sep 30, 2025 | 547.19 Mn |
| Jun 30, 2025 | 607.29 Mn |
| Mar 31, 2025 | 656.16 Mn |
| Dec 31, 2024 | 696.93 Mn |
| Sep 30, 2024 | 719.60 Mn |
| Jun 30, 2024 | 759.58 Mn |
| Mar 31, 2024 | 708.77 Mn |
| Dec 31, 2023 | 388.78 Mn |
| Sep 30, 2023 | 214.21 Mn |
| Jun 30, 2023 | 224.47 Mn |
| Mar 31, 2023 | 224.26 Mn |
| Dec 31, 2022 | 275.52 Mn |
| Sep 30, 2022 | 304.89 Mn |
| Jun 30, 2022 | 328.42 Mn |
| Mar 31, 2022 | 355.18 Mn |
| Dec 31, 2021 | 369.11 Mn |
| Sep 30, 2021 | 350.91 Mn |
API Access
Celldex Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();